Back
Rapt Therapeutics, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
43
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.11
Seasonality Move:
-35.94%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atRapt Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 16.4% based on the past 6 years of stock performance.
-
Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Rapt Therapeutics, Inc. Stock Undervalued?The current Rapt Therapeutics, Inc. [RAPT] share price is $34.73. The Score for RAPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Rapt Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Rapt Therapeutics, Inc. has on average historically risen by 16.4% based on the past 6 years of stock performance.
Rapt Therapeutics, Inc. Stock Rating
Sell
43
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. overpriced?
-
Rapt Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Rapt Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com
52-Week Data
52-Week High:
42.39
52-Week Low:
5.67
Prediction Charts
Market Cap:
574.4M
Price in USD:
34.73
Volume:
137.4K
Beta:
0.32
Technical Analysis
SMA50:
32.11
SMA100:
27.32
SMA200:
18.00
52-Wk Change:
294.66%
Stock Predictions
-
Is Rapt Therapeutics, Inc. stock public?Yes, Rapt Therapeutics, Inc. is a publicly traded company.
-
What is the Rapt Therapeutics, Inc. stock quote today?The Rapt Therapeutics, Inc. stock price is 34.73 USD today.
-
How to buy Rapt Therapeutics, Inc. stock online?You can buy Rapt Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-24 | 35.58 | 35.84 | 36.92 | 34.38 |
| Dec-26 | 35.68 | 35.42 | 35.71 | 34.80 |
| Dec-29 | 35.02 | 35.84 | 36.25 | 34.78 |
| Dec-30 | 35.59 | 33.38 | 35.95 | 33.01 |
| Dec-31 | 33.15 | 33.87 | 34.22 | 33.15 |
| Jan-2 | 33.93 | 31.85 | 34.15 | 31.62 |
| Jan-5 | 31.78 | 29.82 | 32.67 | 29.77 |
| Jan-6 | 29.82 | 30.83 | 32.11 | 29.77 |
| Jan-7 | 31.08 | 32.42 | 33.24 | 31.08 |
| Jan-8 | 32.42 | 31.20 | 32.50 | 31.18 |
| Jan-9 | 32.88 | 33.62 | 33.72 | 32.06 |
| Jan-12 | 33.58 | 34.40 | 34.52 | 32.14 |
| Jan-13 | 34.27 | 34.06 | 34.86 | 32.99 |
| Jan-14 | 34.05 | 34.73 | 35.42 | 33.96 |
Rapt Therapeutics, Inc. Earnings
Rapt Therapeutics, Inc. Earnings Report: Per Share Rapt Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Rapt Therapeutics, Inc. Forecast Revenue Growth
Rapt Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Rapt Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and a decrease next year of $1.06 per share.
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.